Public Health v. Privacy: The Technology of Contact Tracing | McDermott Skip to main content

Public Health v. Privacy: The Technology of Contact Tracing

Public Health v. Privacy: The Technology of Contact Tracing

Overview


Contact tracing is a primary strategy for halting the spread of COVID-19, and privacy implications are crucial to collection methods involving delicate health and location information. Currently government, educational institutions and private sector companies are searching for digital contact tracing options and how to identify solutions quickly and efficiently.

Join McDermott’s Global Head of the Firm’s Privacy and Cybersecurity Practice, Laura Jehl, CSAIL’s Principal Research Scientist, Daniel Weitzner, and other industry speakers for a discussion on contact tracing, privacy implications and transparency in collecting data.

Gain insight into:

  • The balance between efficacy vs. privacy
  • Innovation in the wearable contact tracing space
  • The future of tracing, and scaling this effort across the country

Learn more and watch the video here.

Dig Deeper

London / In-person / September 24, 2026

HPE Europe 2026

Nashville, TN / In-person / May 20 - 21, 2026

McDermott HealthEx 2026

Brussels, Belgium / Speaking Engagements / May 21, 2026

EU Pharmaceutical Law Forum 2026

San Francisco, CA / In-person / April 30, 2026

Health Tech Investment Forum 2026

Orlando, FL / Speaking Engagements / April 23 – 24, 2026

NAMCP 2026 Spring Managed Care Forum

New York, NY / Speaking Engagements / March 25 – 26, 2026

ACI’s FDA Boot Camp